• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    enGene Holdings Inc. - Common Stock (NQ:ENGN)

    7.220 +0.010 (+0.14%)
    Streaming Delayed Price Updated: 9:37 AM EDT, Mar 23, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,124
    Open 7.220
    Bid (Size) 7.100 (2,000)
    Ask (Size) 7.450 (100)
    Prev. Close 7.210
    Today's Range 7.220 - 7.220
    52wk Range 2.650 - 12.25
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This Biotech Was Quietly Bought Before a $58 Per Share Takeout ↗
    This clinical-stage biotech develops oral therapies targeting cancer and inflammatory diseases, with lead candidates in active trials. 
    Via The Motley Fool
    News headline image
    enGene Reports First Quarter 2026 Financial Results and Provides Business Update
    From enGene Holdings Inc.
    Via Business Wire

    Performance

    YTD
    -18.4%
    -18.4%
    1 Month
    -30.3%
    -30.3%
    3 Month
    -17.7%
    -17.7%
    6 Month
    +6.0%
    +6.0%
    1 Year
    +55.9%
    +55.9%

    More News

    Read More
    News headline image
    enGene to Participate in Upcoming Investor Conferences
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene Reports Full Year 2025 Financial Results and Provides Business Update
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene to Present at the Piper Sandler 37th Annual Healthcare Conference
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene Announces Proposed Public Offering of Common Shares
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Dow Gains More Than 300 Points; Energy Vault Holdings Shares Jump ↗
    Via Benzinga
    Topics Stocks
    News headline image
    12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
    Via Benzinga
    News headline image
    EnGene Encouraged By Promising Response Rates In Bladder Cancer Trial ↗
    Via Benzinga
    News headline image
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday ↗
    Via Benzinga
    News headline image
    ENGN Stock Soars On Hopeful Data From Bladder Cancer Study ↗
    Via Stocktwits
    News headline image
    Get insights into the top gainers and losers of Tuesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene to Host Conference Call to Provide Update on Pivotal Cohort of LEGEND Trial
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene to Participate in Upcoming Investor Conferences
    From enGene Holdings Inc.
    Via Business Wire
    News headline image
    enGene Named a BioSpace 2026 Best Places to Work Winner
    From enGene Holdings Inc.
    Via Business Wire

    Frequently Asked Questions

    Is enGene Holdings Inc. - Common Stock publicly traded?
    Yes, enGene Holdings Inc. - Common Stock is publicly traded.
    What exchange does enGene Holdings Inc. - Common Stock trade on?
    enGene Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for enGene Holdings Inc. - Common Stock?
    The ticker symbol for enGene Holdings Inc. - Common Stock is ENGN on the Nasdaq Stock Market
    What is the current price of enGene Holdings Inc. - Common Stock?
    The current price of enGene Holdings Inc. - Common Stock is 7.220
    When was enGene Holdings Inc. - Common Stock last traded?
    The last trade of enGene Holdings Inc. - Common Stock was at 03/23/26 09:37 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.